| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Childrens Hospital and Program for Developmental and Reproductive Biology (M.A., M.H.), Biomedicum Helsinki, and Departments of Obstetrics and Gynecology (L.U.-K., A.L., R.B.) and Pathology (R.B.), University of Helsinki, 00014 Helsinki, Finland; and Department of Pediatrics (M.H.), Washington University School of Medicine, St. Louis, Missouri 63110
Address all correspondence and requests for reprints to: Mikko Anttonen, M.B., Ph.D., Program for Developmental and Reproductive Biology, Biomedicum Helsinki, University of Helsinki, P.O. Box 63 (Haartmaninkatu 8), 00014 Helsinki, Finland. E-mail: mikko.anttonen{at}helsinki.fi.
Context: Granulosa cell tumors (GCTs) are ovarian malignancies that produce estrogens, inhibins, and anti-Müllerian hormone (AMH). The molecular pathogenesis of GCTs is likely to involve defects in the genes regulating normal granulosa cell proliferation during folliculogenesis.
Objective: The objective of this study was to test the role of factors regulating the normal granulosa cell function, i.e. AMH, inhibin-
, SF-1 (steroidogenic factor-1), and GATA transcription factors in the pathobiology and clinical behavior of GCTs.
Design: We selected randomly a cohort of 80 GCT patients treated at our university hospital during 19712003, analyzed protein expression in the tumor samples embedded on a tissue microarray by immunohistochemistry, and correlated the data to clinical and histopathological parameters.
Results: We found no significant differences in the immunoreactivity levels of inhibin-
, GATA-6, FOG-2 (friend of GATA-2), or SF-1 in GCTs compared with normal granulosa cells. AMH expression was, however, low (i.e. reduced) in 69% of GCTs and correlated inversely with tumor size (P = 0.0025). In contrast, GATA-4 expression was high (i.e. resembled normal granulosa cells) in 44% of GCTs and correlated positively with clinical stage and recurrence (P = 0.0232 and P = 0.0038, respectively). Fifty of the 80 patients had a follow-up for at least 10 yr, and 13 of them had recurrence(s). In multivariate analysis of recurrence, the high GATA-4 expression remained the only independent factor (risk ratio, 9.2; 95% confidence interval, 2.043.3; P = 0.0048).
Conclusions: The more aggressive GCTs retain a high GATA-4 expression, whereas the larger tumors lose the proliferation-suppressing AMH expression. The high GATA-4 expression in GCTs may serve as a marker of poor prognosis.
This article has been cited by other articles:
![]() |
A. Kyronlahti, M. Ramo, M. Tamminen, L. Unkila-Kallio, R. Butzow, A. Leminen, M. Nemer, N. Rahman, I. Huhtaniemi, M. Heikinheimo, et al. GATA-4 Regulates Bcl-2 Expression in Ovarian Granulosa Cell Tumors Endocrinology, November 1, 2008; 149(11): 5635 - 5642. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Y. Hui and H. A. LaVoie GATA4 Reduction Enhances 3',5'-Cyclic Adenosine 5'-Monophosphate-Stimulated Steroidogenic Acute Regulatory Protein Messenger Ribonucleic Acid and Progesterone Production in Luteinized Porcine Granulosa Cells Endocrinology, November 1, 2008; 149(11): 5557 - 5567. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Miller and W G. McCluggage Prognostic factors in ovarian adult granulosa cell tumour J. Clin. Pathol., August 1, 2008; 61(8): 881 - 884. [Full Text] [PDF] |
||||
![]() |
R. S. Viger, S. M. Guittot, M. Anttonen, D. B. Wilson, and M. Heikinheimo Role of the GATA Family of Transcription Factors in Endocrine Development, Function, and Disease Mol. Endocrinol., April 1, 2008; 22(4): 781 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Anttonen, H Parviainen, A Kyronlahti, M Bielinska, D B Wilson, O Ritvos, and M Heikinheimo GATA-4 is a granulosa cell factor employed in inhibin-{alpha} activation by the TGF-{beta} pathway. J. Mol. Endocrinol., June 1, 2006; 36(3): 557 - 568. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |